StockData
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN) stock

DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.84−0.08 (-0.81%)

Close on Nov 17, 2026Market cap $615.80MP/E –Yield –

Design Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Design Therapeutics's profit margin for the twelve months ending Dec 31, 2020 was -3663.7%. For fiscal 2020 it was -3663.7%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-3663.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2020Dec 31, 2020-11681.8%–
Q3 FY2020Sep 30, 2020-11600.0%–
Q2 FY2020Jun 30, 2020-4651.6%–
Q1 FY2020Mar 31, 2020-466.9%–

More Design Therapeutics figures

See a number that looks wrong?